Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration
Public ClinicalTrials.gov record NCT03347708. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Double-Blinded, Vehicle- and Placebo-Controlled, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of IDCT in Subjects With Single-Level, Symptomatic Lumbar Intervertebral Disc Degeneration
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the safety and preliminary efficacy of intradiscal injections of two doses of IDCT (Discogenic Cells + Sodium Hyaluronate vehicle) and two controls (saline, Sodium Hyaluronate vehicle) in subjects with chronic low back pain due to Degenerative Disc Disease (DDD) at one lumbar level from L3 to S1.
Study identification
- NCT ID
- NCT03347708
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 25, 2018
- Primary completion
- Jan 31, 2022
- Completion
- Nov 9, 2022
- Last update posted
- Jan 24, 2023
2018 – 2022
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Clinical Therapeutics, LLC | Birmingham | Alabama | 35235 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| UC San Diego CIRM Alpha Stem Cell Clinic | San Diego | California | 92037 | — |
| Source Healthcare | Santa Monica | California | 90403 | — |
| Otrimed | Edgewood | Kentucky | 41017 | — |
| Spine Institute of Louisiana | Shreveport | Louisiana | 71101 | — |
| Orthopedic Center of St. Louis | Chesterfield | Missouri | 63017 | — |
| Ainsworth Institute of Pain Management | New York | New York | 10022 | — |
| Carolina Neurosurgery & Spine Associates | Charlotte | North Carolina | 28204 | — |
| Clinical Investigations, LLC | Edmond | Oklahoma | 73013 | — |
| Clinical Trials of South Carolina | Charleston | South Carolina | 29406 | — |
| Semmes Murphey | Memphis | Tennessee | 38120 | — |
| Physicians' Research Options, LLC | Draper | Utah | 84020 | — |
| Virginia iSpine | Richmond | Virginia | 23235 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03347708, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 24, 2023 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03347708 live on ClinicalTrials.gov.